ArticleNature cancer2025
Retargeted oncolytic viruses engineered to remodel the tumor microenvironment for glioblastoma immunotherapy.
Federico Giovannoni et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it